BIT 0.00% 1.9¢ biotron limited

The silence from BIT management is deafening! Surely we must be...

  1. 20,253 Posts.
    lightbulb Created with Sketch. 1789
    The silence from BIT management is deafening!
    Surely we must be due for an update?
    Does BIT225 work or not?
    I know that in medical science they can talk about a drug in many different ways, which makes it hard for a layman to understand whether they are talking about the same thing or not? what I want to know is our drug a good thing or not?

    I found this in my travels which says it doesn't work?
    https://www.researchgate.net/figure...-we-show-the-chemical-structure_fig1_40482779

    ). JK3/32 was also superior to a clinically progressed compound, BIT225 26,27 , which, in our hands, showed no antiviral activity discernible from effects upon cellular viability (figure S3). Thus, we propose that the favourable potency and selectivity index demonstrated by JK3/32 could serve as a high quality starting point for a more comprehensive p7-targeted inhibitor drug development programme. ...

    Come on MM we deserve some sort of explanation I believe?
    Last edited by moosey: 03/06/20
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.